How well does loncastuximab tesirine work after chimeric antigen receptor T-cell treatment in diffuse large B-cell lymphoma? A plain language summary of a real-world evidence study
Authors
Gary Milligan (ORCID: https://orcid.org/0000-0002-1427-3339)
How well does loncastuximab tesirine work after chimeric antigen receptor T-cell treatment in diffuse large B-cell lymphoma? A plain language summary of a real-world evidence study
Gary Milligan, Melanie Lucero, Jolenta Cheung, Narendranath Epperla et al.
Journal
Future Oncology
Topics
CAR-T cell therapy research
article
How well does loncastuximab tesirine work after chimeric antigen receptor T-cell treatment in diffuse large B-cell lymphoma? A plain language summary of a real-world evidence study
Gary Milligan, Melanie Lucero, Jolenta Cheung, Narendranath Epperla, Laura Mirams, Mona Amet, Lei Chen, Tom Bailey
article en
Abstract
No abstract available for this paper.
Publication Tag
Future OncologyVol. 21(15)
Institutions
Providence College (US), University of Utah (US), Huntsman Cancer Institute (US), Adelphi Group (United Kingdom) (GB)